Literature DB >> 1752848

Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia.

A J Rothschild1, C A Locke.   

Abstract

Considerable controversy exists regarding the relationship between fluoxetine and the emergence of suicidal ideation. Three cases are presented of patients who were reexposed to fluoxetine after having previously made a serious suicide attempt during fluoxetine treatment. All three patients developed severe akathisia during retreatment with fluoxetine and stated that the development of the akathisia made them feel suicidal and that it had precipitated their prior suicide attempts. The akathisia and suicidal thinking abated upon the discontinuation of the fluoxetine or the addition of propranolol. The emergence of suicidal ideation during treatment with fluoxetine may be secondary to the development of akathisia. Gradual increments of fluoxetine dose and the prompt recognition and treatment of akathisia may reduce further the rare occurrence of suicidal ideation during fluoxetine treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752848

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  20 in total

Review 1.  Antidepressants and suicide: risk-benefit conundrums.

Authors:  David Healy; Chris Whitaker
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

Review 2.  Suicidality with selective serotonin reuptake inhibitors: Valid claim?

Authors:  Yvon D Lapierre
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

3.  Toxicological findings in suicides - frequency of antidepressant and antipsychotic substances.

Authors:  Maximilian Methling; Franziska Krumbiegel; Sven Hartwig; Maria K Parr; Michael Tsokos
Journal:  Forensic Sci Med Pathol       Date:  2018-11-05       Impact factor: 2.007

Review 4.  Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials.

Authors:  Dean Fergusson; Steve Doucette; Kathleen Cranley Glass; Stan Shapiro; David Healy; Paul Hebert; Brian Hutton
Journal:  BMJ       Date:  2005-02-19

5.  Safe use of SSRIs in young adults: how strong is evidence for new suicide warning?

Authors:  Michael F Grunebaum; J John Mann
Journal:  Curr Psychiatr       Date:  2007-11

Review 6.  Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Authors:  Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan J Stein; Rajiv Tandon; Marcio Versiani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-08       Impact factor: 5.270

7.  Treatment Emergent Suicidal Ideation in depressed older adults.

Authors:  Pilar Cristancho; Brendan O'Connor; Eric J Lenze; Daniel M Blumberger; Charles F Reynolds; David Dixon; Benoit H Mulsant
Journal:  Int J Geriatr Psychiatry       Date:  2016-05-09       Impact factor: 3.485

8.  The Food and Drug Administration's deliberations on antidepressant use in pediatric patients.

Authors:  Laurel K Leslie; Thomas B Newman; P Joan Chesney; James M Perrin
Journal:  Pediatrics       Date:  2005-07       Impact factor: 7.124

9.  The Fluoxetine and Suicide Controversy : A Review of the Evidence.

Authors:  D Healy
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

10.  Extrapyramidal side effects and suicidal ideation under fluoxetine treatment: a case report.

Authors:  Christos Christodoulou; Athanasia Papadopoulou; Emmanouil Rizos; Kalliopi Tournikioti; Xenia Gonda; Athanassios Douzenis; Lefteris Lykouras
Journal:  Ann Gen Psychiatry       Date:  2010-01-18       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.